[1]CurrentPatentAssignee:ELILILLY&CO-US2016/96823,2016,A1Locationinpatent:Paragraph0099-0100
[1]CurrentPatentAssignee:ELILILLY&CO-US2016/96823,2016,A1Locationinpatent:Paragraph0102-0103
[1]CurrentPatentAssignee:ELILILLY&CO-US2016/96823,2016,A1Locationinpatent:Paragraph0105-0106
[1]CurrentPatentAssignee:ELILILLY&CO-US2016/96823,2016,A1Locationinpatent:Paragraph0083-0084
[1]CurrentPatentAssignee:ELILILLY&CO-US2016/96823,2016,A1
[2]CurrentPatentAssignee:ELILILLY&CO-US2016/96823,2016,A1
Title: Huaxing Pei, et al. Abstract 955: LY3200882, a novel, highly selective TGFβRI small molecule inhibitor. AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 955.
Title: Xu G, et al. Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors. Eur J Med Chem. 2020 Apr 29;198:112354.